Board of Directors
Co-Director Geoffrey Tabin, MD, Professor of Ophthalmology & Visual Sciences, Director, Division of International Ophthalmology, John A. Moran Eye Center, University of Utah, Utah, USA.
Co-Director Sanduk Ruit, MD, Medical Director, Tilganga Eye Centre, Kathmandu, Nepal.
Adrienne Graves, PhD, Independent Director, Akorn Inc, TearLab Corporation, Aerpio Therapeutics, and EncoreVision. Past President and CEO, Santen Inc., California, USA.
Matthew Oliva, MD, Associate Clinical Professor, Division of International Ophthalmology, Casey Eye Institute, Oregon Health Sciences University and Private Practice Ophthalmologist, Oregon, USA.
Randall Olson, MD, Professor and Chairman; Director, John A. Moran Eye Center, University of Utah, Utah, USA.
Hugh Taylor, MD, Professor, Melbourne School of Population Health, University of Melbourne. Vice President, International Agency for the Prevention of Blindness.
Further Background on Board Members
More on Co-Director Geoffrey Tabin, MD
More on Co-Director Sanduk Ruit, MD
Adrienne Graves, PhD
- Adrienne Graves
Adrienne L. Graves, Ph.D. is a visual scientist by training and a global industry leader in ophthalmology. From 2002 to 2010, Dr. Graves was President and Chief Executive Officer of Santen Inc., the US arm of Japan's largest ophthalmic pharmaceutical company. She joined Santen in 1995 as VP of Clinical Affairs to initiate clinical development in the US, and was responsible for 3 NDA approvals. She was promoted to Sr. VP of Worldwide Clinical Affairs (Japan, US, and Europe), and was subsequently named a global Corporate Officer and CEO of US operations. Prior to joining Santen, Dr. Graves spent nine years with Alcon Laboratories, Inc., beginning in 1986 as a Senior Scientist. She progressed through various roles, including Director of International Ophthalmology. Dr. Graves currently serves as an Independent Director on the following corporate boards: Akorn, Inc., TearLab Corporation, Aerpio, and Encore Vision. She is also a Director on the following Foundation Boards: American Society of Cataract and Refractive Surgery (ASCRS) Foundation, Glaucoma Research Foundation, American Academy of Ophthalmology (AAO) Foundation (Emeritus), Himalayan Cataract Project, Pan-American Ophthalmology Foundation, and KeepYourSight Foundation; she also serves on the Corporation Committee for the Brown University Medical School and the Advisory Board for Amach Capital Partners. Dr. Graves cofounded Glaucoma 360 and Ophthalmic Women Leaders (OWL). She received her AB in Psychology with honors from Brown University, her PhD in Psychobiology from the University of Michigan, and she completed a postdoctoral fellowship in visual neuroscience at the University of Paris.
Matthew Oliva, MD
- Dr. Oliva with patients in Ethiopia.
Dr. Oliva is Associate Clinical Professor in the Division of International Ophthalmology at Casey Eye Institute and Oregon Health Sciences University and a private practice ophthalmologist in Medford, Oregon. He is also an associate medical director for SightLife Eye Bank with a focus on international eyebank development and eliminating corneal blindness worldwide. As a fellowship-trained corneal surgeon, he specializes in surgical and medical treatments of the anterior eye. He completed his ophthalmology residency at the University of Washington and a fellowship in corneal diseases/corneal transplantation/and refractive surgery in Melbourne Australia at the Royal Victorian Eye and Ear Hospital. He has a special interest in international cataract and corneal blindness and travels several times a year to the Himalayas and Africa to perform surgeries and teach resident physicians.
- Dr. Olson
Randall Olson, MD
Dr. Olson is Professor and Chairman of Ophthalmology & Visual Sciences at the University of Utah School of Medicine and Director of the John A. Moran Eye Center at the University of Utah. He is one of the most respected and noted ophthalmologists in the country with a practice focused on all areas of cornea and external disease, as well as other anterior segment disorders. He has a special interest in intraocular lens related complications.
Hugh Taylor, MD
- Dr. Taylor
Doctor and Professor Hugh Taylor won the 2001 Lifetime Achievement Award from the American Academy of Ophthalmology for humanitarian service. He has held many positions in the World Health Organization program against blindness, and is currently the Asian and Pacific Coordinator for the WHO project called Vision Twenty-Twenty, designed to eliminate treatable blindness by the year 2020. Taylor is the former medical director of the Fred Hollows Foundation and was a professor and director of the Dana Center for International Ophthalmology at the Johns Hopkins Medical School before returning to his native Australia. He is the most widely published ophthalmologist in Australia. His research into the second and fourth causes of world blindness, trachoma and onchocercasias, has earned him a prestigious reputation in the field of international ophthalmology.
- Dr. Taylor doing an eye exam.
See also:
- Taylor's interview in article called "Tackling Trachoma"
- "Eye Care: Dollars and Sense" [PDF, 117Kb], the 63rd Edward Jackson Lecture by Hugh R. Taylor AC MD
